Abbott Molecular, Inc. FDA Record
- Latest inspection VAI · Jan 27, 2023
- 5 Class I recalls
- Last warning letter 2009
Abbott Molecular, Inc. has 36 FDA recalls (5 Class I), 16 inspections, 19 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Abbott Molecular, Inc., the most recent on Aug 12, 2009.
- Latest recall
- Z-0191-2027 · Sep 10, 2026 · filed under Abbott
- Latest recall under this name
- Z-1749-2025 · Class II · Apr 28, 2025
- Latest inspection
- Jan 27, 2023 · VAI
- Latest 510(k)
- Sep 25, 2025
Newer recall under related name Abbott: Sep 10, 2026, Z-0191-2027.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 36 (5 Class I) | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 19 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 16 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 1 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Abbott Molecular, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 3 | 0 |
| 2024 | 0 | 0 | 0 | 6 | 0 |
| 2023 | 1 | 0 | 0 | 1 | 0 |
| 2022 | 0 | 0 | 0 | 10 | 0 |
| 2021 | 1 | 0 | 0 | 10 | 5 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Abbott Molecular, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Abbott Molecular, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Abbott Molecular, Inc. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Aug 12, 2009 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-1749-2025 | Class II | Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription… | Apr 28, 2025 |
| Z-1748-2025 | Class II | Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a multiplex real-time… | Apr 28, 2025 |
| Z-1665-2025 | Class II | The Alinity m System is designed to automate the steps for nucleic acid testing. Model Numbers… | Mar 20, 2025 |
| Z-0233-2025 | Class II | Abbott Alinity m HPV AMP Kit, used with the Alinity m System, product codes: a) REF 09N15-095; b)… | Sep 12, 2024 |
| Z-0234-2025 | Class II | Abbott Alinity m STI AMP Kit, used with the Alinity m System, product codes: a) REF 09N17-095; b)… | Sep 12, 2024 |
| Z-1602-2024 | Class II | Alinity m System, Part Number: 08N53-002 | Mar 20, 2024 |
| Z-1190-2024 | Class III | Wash station: M1000 Wash Station Assembly & DITI Slide, REF 04J72-28* (*This part number is a spare… | Feb 1, 2024 |
| Z-1189-2024 | Class III | In-vitro diagnostic kits: (1) Abbott Vysis LSI ATM (11q22.3) SpectrmOrange Probe, REF 01N33-020… | Feb 1, 2024 |
| Z-1188-2024 | Class III | In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2)… | Feb 1, 2024 |
| Z-0407-2024 | Class II | Alinity m HCV AMP kit, List (REF) Numbers: a) 08N50-095 and b) 08N50-090. The Alinity m HCV assay… | Oct 30, 2023 |
| Z-1009-2023 | Class II | Alinity m System. The Alinity m System is designed to automate the steps for nucleic acid… | Dec 9, 2022 |
| Z-0740-2023 | Class II | Abbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-090 | Nov 22, 2022 |
| Z-0739-2023 | Class II | Abbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-096 | Nov 22, 2022 |
| Z-1349-2023 | Class II | Abbott Alinity m System, REF 08N53-002, containing Amplification Detetction Unit (ADU) #4. | Nov 11, 2022 |
| Z-0268-2023 | Class II | Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use | Oct 12, 2022 |
| Z-1679-2022 | Class II | Abbott Alinity m SARS-CoV-2 CTRL Kit, REF 09N78-085, each kit contains 12 x 1.3mL CTRL - and 12 x… | Aug 19, 2022 |
| Z-1518-2022 | Class II | The Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use. | Jul 19, 2022 |
| Z-0883-2022 | Class II | Alinity m HBV Application Specification File (US and CE) | Mar 4, 2022 |
| Z-0884-2022 | Class II | Alinity m HBV AMP Kit (US and CE) | Mar 4, 2022 |
| Z-0710-2022 | Class II | Alinity m Integrated Reaction Units (IRU) | Feb 11, 2022 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jan 27, 2023 | Des Plaines, IL | Devices | Voluntary Action Indicated (VAI) | 3005248192 |
| Feb 19, 2021 | Des Plaines, IL | Devices | No Action Indicated (NAI) | 3005248192 |
| Jul 10, 2019 | Des Plaines, IL | Devices | No Action Indicated (NAI) | 3005248192 |
| Sep 20, 2018 | Des Plaines, IL | Biologics | No Action Indicated (NAI) | 3005248192 |
| May 4, 2017 | Des Plaines, IL | Devices | No Action Indicated (NAI) | 3005248192 |
| Mar 31, 2016 | Des Plaines, IL | Devices | No Action Indicated (NAI) | 3005248192 |
| Feb 3, 2016 | Des Plaines, IL | Devices | No Action Indicated (NAI) | 3005248192 |
| Jul 11, 2014 | Des Plaines, IL | Devices | Voluntary Action Indicated (VAI) | 3005248192 |
| Feb 21, 2013 | Des Plaines, IL | Devices | No Action Indicated (NAI) | 3005248192 |
| Jul 11, 2012 | Des Plaines, IL | Devices | Voluntary Action Indicated (VAI) | 3005248192 |
| Jun 1, 2011 | Des Plaines, IL | Devices | Voluntary Action Indicated (VAI) | 3005248192 |
| May 24, 2011 | Des Plaines, IL | Devices | Voluntary Action Indicated (VAI) | 3005248192 |
| Jul 23, 2010 | Des Plaines, IL | Devices | Voluntary Action Indicated (VAI) | 3005248192 |
| Mar 10, 2010 | Des Plaines, IL | Devices | Voluntary Action Indicated (VAI) | 3005248192 |
| Jun 29, 2009 | Des Plaines, IL | Devices | Official Action Indicated (OAI) | 3005248192 |
| Feb 13, 2009 | Des Plaines, IL | Devices | Voluntary Action Indicated (VAI) | 3005248192 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Abbott Molecular, Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3005248192 | Des Plaines, IL | 16 | Jan 27, 2023 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K252102 | Alinity m HCV | Sep 25, 2025 |
| K243489 | Alinity m EBV (09N43-095) | Jul 28, 2025 |
| K243485 | Alinity m CMV | Jul 1, 2025 |
| K241921 | Alinity m BKV | Mar 24, 2025 |
| K241573 | Alinity m Resp-4-Plex | Feb 14, 2025 |
| K243410 | simpli-COLLECT STI Test | Jan 30, 2025 |
| K241580 | Alinity m SARS-CoV-2 AMP Kit (09N78-096); Alinity m SARS-CoV-2 CTRL Kit (09N78-086) | Dec 6, 2024 |
| K233349 | Alinity m HSV 1 & 2 / VZV | May 3, 2024 |
| K222379 | Alinity m STI Assay | Mar 3, 2023 |
| K212778 | Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m… | Jul 15, 2022 |
| K202977 | Alinity m STI Assay | Apr 29, 2022 |
| K140354 | ABBOTT MULTI-COLLECT SPECIMEN COLLECTION KIT, ABBOTT REAL TIME CT/NG | May 9, 2014 |
| K131508 | VYSIS D7S486/CEP 7 FISH PROBE KIT | Sep 13, 2013 |
| DEN130010 | VYSIS EGR1 FISH PROBE KIT - SC (SPECIMEN CHARACTERIZATION) | Jul 29, 2013 |
| K091960 | VYSIS EGR1 FISH PROBE KIT (VYSIS LSI EGR1 SPECTRUM/ORANGE/D5S23, D5S721, SPECTRUM GREEN PROBE)… | Aug 29, 2011 |
| K100015 | VYSIS CLL FISH PROBE KIT (VYSIS LSI TP53 SPECTRUMORANGE/ATM SPECTRUMGREEN) AND LSI D135319… | Aug 9, 2011 |
| K092704 | ABBOTT REALTIME CT/NG AND ABBOTT MULTI-COLLECT SPECIMEN COLLECTION KIT, MODELS 8L07-91, 9K12-03 | May 28, 2010 |
| K092705 | ABBOTT M2000SP AND ABBOTT M2000RT, MODELS 9K14-01 (G-SERIES), 9K14-02 (E-SERIES), 9K1501 | May 28, 2010 |
| K080739 | ABBOTT REALTIME CT/NG ASSAY AND MULTI-COLLECT SPECIMEN COLLECTION KIT | Jul 10, 2008 |
Abbott Molecular, Inc. and the FDA: common questions
Has Abbott Molecular, Inc. received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Abbott Molecular, Inc.. The most recent is dated Aug 12, 2009.
Has Abbott Molecular, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Abbott Molecular, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Abbott Molecular, Inc.?
The most recent FDA inspection on file ended Jan 27, 2023 at Des Plaines, IL and was classified VAI. FDA has 16 inspections of Abbott Molecular, Inc. on file, 1 of them classified OAI (official action indicated).
Has Abbott Molecular, Inc. had an FDA recall?
Yes. Abbott Molecular, Inc. has 36 FDA recalls on record, 5 of them Class I, the most serious class. The most recent under this name started Apr 28, 2025. A newer recall, dated Sep 10, 2026, is filed under the related name Abbott.
Need more than this page shows? Ask about Abbott Molecular, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.